Literature DB >> 15052275

GM1 ganglioside regulates the proteolysis of amyloid precursor protein.

Q Zha1, Y Ruan, T Hartmann, K Beyreuther, D Zhang.   

Abstract

Plaques containing amyloid beta-peptides (Abeta) are a major feature in Alzheimer's disease (AD), and GM1 ganglioside is an important component of cellular plasma membranes and especially enriched in lipid raft. GM1-bound Abeta (GM1/Abeta), found in brains exhibiting early pathological changes of AD including diffuse plaques, has been suggested to be involved in the initiation of amyloid fibril formation in vivo by acting as a seed. However, the role of GM1 in amyloid beta-protein precursor (APP) processing is not yet defined. In this study, we report that exogenous GM1 ganglioside promotes Abeta biogenesis and decreases sAPPalpha secretion in SH-SY5Y and COS7 cells stably transfected with human APP695 cDNA without affecting full-length APP and the sAPPbeta levels. We also observe that GM1 increases extracellular levels of Abeta in primary cultures of mixed rat cortical neurons transiently transfected with human APP695 cDNA. These findings suggest a regulatory role for GM1 in APP processing pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052275     DOI: 10.1038/sj.mp.4001509

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  34 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

2.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

Review 3.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

4.  Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study.

Authors:  N Mattsson; H Zetterberg; S Bianconi; N M Yanjanin; R Fu; J-E Månsson; F D Porter; K Blennow
Journal:  Neurology       Date:  2010-12-29       Impact factor: 9.910

5.  Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.

Authors:  Seyedmehdi Hossaini Nasr; Hovig Kouyoumdjian; Christiane Mallett; Sherif Ramadan; David C Zhu; Erik M Shapiro; Xuefei Huang
Journal:  Small       Date:  2017-11-14       Impact factor: 13.281

6.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

Review 7.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

8.  Direct and potent regulation of gamma-secretase by its lipid microenvironment.

Authors:  Pamela Osenkowski; Wenjuan Ye; Rong Wang; Michael S Wolfe; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

9.  Development of photocrosslinked sialic acid containing polymers for use in Abeta toxicity attenuation.

Authors:  Christopher B Cowan; Gerard L Coté; Theresa A Good
Journal:  Biomaterials       Date:  2008-06-03       Impact factor: 12.479

10.  Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.

Authors:  You-hai Xu; Kui Xu; Ying Sun; Benjamin Liou; Brian Quinn; Rong-hua Li; Ling Xue; Wujuan Zhang; Kenneth D R Setchell; David Witte; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2014-03-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.